# Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer

> **NCT05252065** · — · UNKNOWN · sponsor: **Guizhou Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **OTHER:** Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging

## Key facts

- **NCT ID:** NCT05252065
- **Lead sponsor:** Guizhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05252065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05252065, "Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05252065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*